ITRM•benzinga•
HC Wainwright & Co. Assumes Iterum Therapeutics at Buy, Announces Price Target of $9
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga